GO
| HSI1 | 27,266.38 | +83.23 | 217.22B |
| HSCEI1 | 9,268.18 | +25.43 | 79.87B |
| Back Zoom + Zoom - Block Traded | |
|
2026-02-11 14:36:47 WUXI BIO (02269.HK) has issued a positive profit alert for 2H25, according to a CLSA research report. The company estimated its revenue to have logged a basically in-line growth of 17% YoY, while its net profit and adjusted net profit will have increased by 38% and 31% YoY to RMB2.6 billion and RMB3.7 billion, both significantly exceeding market expectations. In CLSA's opinion, an expected YoY growth of 6.2 ppts in WUXI BIO's gross profit margin to 48.8% was a core positive surprise in this profit alert and a major driver of the better-than-expected earnings performance. CLSA has kept WUXI BIO as one of its top picks for China's CRO and CDMO industries. WUXI BIO's target price remains at HKD48.5, with an Outperform rating. ~ AAStocks Financial News Web Site: www.aastocks.com | |